Physician profile
John D Blevins
NPI 1467423608
$1,640.02
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $950 · 2020: $201 · 2021: $393 · 2022: $95.14.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $302.34 | 2021-2022 | |
| Amgen INC. | $232.60 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $137.24 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $134.98 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $130.60 | 2019 | |
| Ge Healthcare | $119.60 | 2019 | |
| Insulet Corporation | $69.19 | 2019 | |
| Acadia Pharmaceuticals INC | $62.58 | 2019-2020 | |
| Allergan, INC. | $50.66 | 2020 | |
| Mallinckrodt Enterprises LLC | $49.55 | 2019 | |
| Upsher-Smith Laboratories LLC | $36.39 | 2019 | |
| Boston Scientific Corporation | $31.44 | 2019 | |
| Amneal Pharmaceuticals LLC | $28.40 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $25.91 | 2021 | |
| Genzyme Corporation | $24.83 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $22.63 | 2019 | |
| Bausch Health US, LLC | $22.23 | 2019 | |
| Biotronik INC. | $20.05 | 2021 | |
| Alexion Pharmaceuticals, INC. | $19.70 | 2019 | |
| Avanir Pharmaceuticals, INC. | $19.07 | 2019 | |
| Greenwich Biosciences, INC. | $17.73 | 2019 | |
| Lilly USA, LLC | $15.89 | 2019 | |
| Shire North American Group INC | $14.58 | 2019 | |
| Pfizer INC. | $14.04 | 2021 | |
| Genentech USA, INC. | $13.88 | 2019 | |
| Novo Nordisk INC | $12.71 | 2020 | |
| Grifols USA, LLC | $11.20 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Blevins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.